Board of Directors
Allan holds an MBA from Laval University in Quebec and is a graduate of ESIEE in biotechnologies. He has experience as a company founder and support manager for innovative start-ups in the healthcare sector. He has been leading this start-up project since 2013, and as Managing Director, he brings his skills to guide and implement the company's strategic decisions.
Allan holds an MBA from Laval University in Quebec and is a graduate of ESIEE in biotechnologies. He has experience as a company founder and support manager for innovative start-ups in the healthcare sector. He has been leading this start-up project since 2013, and as Managing Director, he brings his skills to guide and implement the company's strategic decisions.
Leila NICOLAS holds a Master's degree in Cell Biology and a Master's degree in Healthcare Business Management. She has worked in marketing and business development for nearly 10 years in the pharmaceutical industry and in two life sciences start-ups. Leila joined GO Capital in 2013, where she manages healthcare investments, mainly in seed stage, in both medical technology and drug development companies.
Leila NICOLAS holds a Master's degree in Cell Biology and a Master's degree in Healthcare Business Management. She has worked in marketing and business development for nearly 10 years in the pharmaceutical industry and in two life sciences start-ups. Leila joined GO Capital in 2013, where she manages healthcare investments, mainly in seed stage, in both medical technology and drug development companies.
Sébastien Dias, a medical doctor and HEC graduate, has 20 years' experience in consulting and management in the healthcare industry. Previously a consultant at McKinsey and Director of Becton Dickinson France, he currently advises start-ups and major corporations on strategic and operational issues. He also sits on the strategic boards of Ipso Médical, Cureety and Horiana.
Sébastien Dias, a medical doctor and HEC graduate, has 20 years' experience in consulting and management in the healthcare industry. Previously a consultant at McKinsey and Director of Becton Dickinson France, he currently advises start-ups and major corporations on strategic and operational issues. He also sits on the strategic boards of Ipso Médical, Cureety and Horiana.
Hilja Ibert, PhD brings more than 30 years of experience from the life science industry with leadership roles at international companies like Hologic, Becton Dickinson and bioMérieux. The last 10 years, Hilja Ibert had been fully dedicated to the clinical diagnostics market as CEO of miDiagnostics, followed by Gentian Diagnostics, a Norwegian publicly listed company. In April 2024, Hilja Ibert has been elected as Chairperson of the Board of Gentian Diagnostics. Since 2023, she is a Member of the Board of Gradientech, a Swedish company, which is fully dedicated to the microbiology market.
Hilja Ibert, PhD brings more than 30 years of experience from the life science industry with leadership roles at international companies like Hologic, Becton Dickinson and bioMérieux. The last 10 years, Hilja Ibert had been fully dedicated to the clinical diagnostics market as CEO of miDiagnostics, followed by Gentian Diagnostics, a Norwegian publicly listed company. In April 2024, Hilja Ibert has been elected as Chairperson of the Board of Gentian Diagnostics. Since 2023, she is a Member of the Board of Gradientech, a Swedish company, which is fully dedicated to the microbiology market.
Allan holds an MBA from Laval University in Quebec and is a graduate of ESIEE in biotechnologies. He has experience as a company founder and support manager for innovative start-ups in the healthcare sector. He has been leading this start-up project since 2013, and as Managing Director, he brings his skills to guide and implement the company's strategic decisions.
Allan holds an MBA from Laval University in Quebec and is a graduate of ESIEE in biotechnologies. He has experience as a company founder and support manager for innovative start-ups in the healthcare sector. He has been leading this start-up project since 2013, and as Managing Director, he brings his skills to guide and implement the company's strategic decisions.
Leila NICOLAS holds a Master's degree in Cell Biology and a Master's degree in Healthcare Business Management. She has worked in marketing and business development for nearly 10 years in the pharmaceutical industry and in two life sciences start-ups. Leila joined GO Capital in 2013, where she manages healthcare investments, mainly in seed stage, in both medical technology and drug development companies.
Leila NICOLAS holds a Master's degree in Cell Biology and a Master's degree in Healthcare Business Management. She has worked in marketing and business development for nearly 10 years in the pharmaceutical industry and in two life sciences start-ups. Leila joined GO Capital in 2013, where she manages healthcare investments, mainly in seed stage, in both medical technology and drug development companies.
Sébastien Dias, a medical doctor and HEC graduate, has 20 years' experience in consulting and management in the healthcare industry. Previously a consultant at McKinsey and Director of Becton Dickinson France, he currently advises start-ups and major corporations on strategic and operational issues. He also sits on the strategic boards of Ipso Médical, Cureety and Horiana.
Sébastien Dias, a medical doctor and HEC graduate, has 20 years' experience in consulting and management in the healthcare industry. Previously a consultant at McKinsey and Director of Becton Dickinson France, he currently advises start-ups and major corporations on strategic and operational issues. He also sits on the strategic boards of Ipso Médical, Cureety and Horiana.
Hilja Ibert, PhD brings more than 30 years of experience from the life science industry with leadership roles at international companies like Hologic, Becton Dickinson and bioMérieux. The last 10 years, Hilja Ibert had been fully dedicated to the clinical diagnostics market as CEO of miDiagnostics, followed by Gentian Diagnostics, a Norwegian publicly listed company. In April 2024, Hilja Ibert has been elected as Chairperson of the Board of Gentian Diagnostics. Since 2023, she is a Member of the Board of Gradientech, a Swedish company, which is fully dedicated to the microbiology market.
Hilja Ibert, PhD brings more than 30 years of experience from the life science industry with leadership roles at international companies like Hologic, Becton Dickinson and bioMérieux. The last 10 years, Hilja Ibert had been fully dedicated to the clinical diagnostics market as CEO of miDiagnostics, followed by Gentian Diagnostics, a Norwegian publicly listed company. In April 2024, Hilja Ibert has been elected as Chairperson of the Board of Gentian Diagnostics. Since 2023, she is a Member of the Board of Gradientech, a Swedish company, which is fully dedicated to the microbiology market.
- VitaDX raised €1.2 million in July 2015 from 28 individual French shareholders as well as a Singaporean and an American for investments between 10 and €30k.
- In June 2017, VitaDX completed a second fundraising of €1.5 million from two investment funds Go Capital and Auriga Partners and two private investors.
- In 2019-2020, VitaDX raised €5 million from the historical venture capital funds Go Capital, Auriga Partners, FFBB Management and also from a new fund Odyssee Venture to support the finalization of VisioCyt®.